0001213900-23-041642.txt : 20230519 0001213900-23-041642.hdr.sgml : 20230519 20230519181549 ACCESSION NUMBER: 0001213900-23-041642 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230517 FILED AS OF DATE: 20230519 DATE AS OF CHANGE: 20230519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROSE ERIC A MD CENTRAL INDEX KEY: 0001139301 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39421 FILM NUMBER: 23941872 MAIL ADDRESS: STREET 1: 161 FORT WASHINGTON AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10032 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Orchestra BioMed Holdings, Inc. CENTRAL INDEX KEY: 0001814114 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 UNION SQUARE DRIVE CITY: NEW HOPE STATE: PA ZIP: 18938 BUSINESS PHONE: 646-343-9298 MAIL ADDRESS: STREET 1: 150 UNION SQUARE DRIVE CITY: NEW HOPE STATE: PA ZIP: 18938 FORMER COMPANY: FORMER CONFORMED NAME: Health Sciences Acquisitions Corp 2 DATE OF NAME CHANGE: 20200603 4 1 ownership.xml X0407 4 2023-05-17 0 0001814114 Orchestra BioMed Holdings, Inc. OBIO 0001139301 ROSE ERIC A MD C/O ORCHESTRA BIOMED HOLDINGS, INC. 150 UNION SQUARE DRIVE NEW HOPE PA 18938 1 0 0 0 0 Common Stock, par value $0.0001 per share ("Common Stock") 2023-05-17 4 M 0 2325 1.08 A 2325 D Common Stock 2023-05-17 4 F 0 157 16.04 D 2168 D Warrant (Right to Buy) 1.08 2023-05-17 4 M 0 2325 0 D 2023-01-26 2023-05-31 Common Stock 2325 0 D On May 17, 2023, the Reporting Person exercised a warrant to purchase 2,325 shares of Common Stock at an exercise price $1.08 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Orchestra BioMed Holdings, Inc. (the "Issuer") withholding 157 of the warrant shares to pay the exercise price and issuing the Reporting Person the remaining 2,168 shares of Common Stock. Represents the shares of Common Stock deemed withheld by the Issuer in connection with the cashless exercise. Pursuant to Section 3(c) of the warrant, the price was calculated as the average closing price per share of Common Stock for the 20 trading days immediately preceding the date on which the notice of exercise was deemed to have been sent to the Issuer. /s/ Matthew R. Schob, Attorney-in-Fact 2023-05-19